Your search returned 2 results.

Results
	1.	Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models. [electronic resource] by Johnson, Michael P Muhlhauser, Mark A Nisenbaum, Eric S Simmons, Rosa M A Forster, Beth M Knopp, Kelly L Yang, Lijuan Morrow, Denise Li, Dominic L Kennedy, Jeffrey D Swanson, Steven Monn, James A Producer: 20171013 In: British journal of pharmacology vol. 174 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headache. [electronic resource] by Blanco, Maria-Jesus Benesh, Dana R Knobelsdorf, James A Khilevich, Albert Cortez, Guillermo S Mokube, Fese Aicher, Thomas D Groendyke, Todd M Marmsater, Fredrik P Tang, Tony P Johnson, Kirk W Clemens-Smith, Amy Muhlhauser, Mark A Swanson, Steven Catlow, John Emkey, Renee Johnson, Michael P Schkeryantz, Jeffrey M Producer: 20170627 In: Bioorganic & medicinal chemistry letters vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search